Combining car t cell therapy and oncolytic virotherapy for pediatric solid tumors: a promising option

HIGHLIGHTS

• who: Jiasen He et al. from the Department of Pediatrics-Patient Care, The University of Texas MD Anderson Cancer Center, Houston, TX, USA have published the paper: Combining CAR T Cell Therapy and Oncolytic Virotherapy for Pediatric Solid Tumors: A Promising Option, in the Journal: Immuno 2023, 3, FOR PEER REVIEW of 14/Dec/2020
• what: In a few of the studies, immunocompetent mice with syngeneic tumors were used to test the efficacy of the combination of mouse CAR T_cells and OVs .
• how: Most of the studies were conducted in immunodeficient mice with . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.